Efficacy
SD
TOLERANCE
A detailed analysis of the treatment group at different time points revealed that the glucose marker values consistently declined over time (Fig. 
Changes in glycemic control markers (mean ± SD) in the treatment and control groups at different time points across FPG (mmol/L), FI (µIU/mL), 2 h-OGTT (mmol/L), HbAAll measured glycemic control markers showed a significant reduction over time in the treatment group. From tFPG after 84 days was significantly lower in the treatment group than in the control group, with a mean FPG of 5.33 ± 0.28 mmol/L for the treatment group and 6.16 ± 0.44 mmol/L for the control group (
Changes in FPG, FI, 2 h-OGTT, HbAFPG: Fasting Plasma Glucose; FI: Fasting Insulin; 2 h-OGTT: 2-hour Oral Glucose Tolerance Test; HBA1c: Hemoglobin A1c; HOMA-IR: homeostatic model assessment-insulin resistance. All values represent means. *ANOVA p-values for differences between day 84 and day 0<10